• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Maternal Use of Weight Loss Products and the Risk of Neural Tube Defects in Offspring: A Systematic Literature Review.母亲使用减肥产品与子女神经管缺陷风险:系统文献回顾。
Birth Defects Res. 2018 Jan 15;110(1):48-55. doi: 10.1002/bdr2.1116. Epub 2017 Oct 12.
2
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
4
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.不同的皮质类固醇药物和方案用于加速有早产风险的婴儿的胎儿肺成熟。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.
5
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
6
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
7
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
8
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
9
Antioxidants for male subfertility.抗氧化剂治疗男性不育。
Cochrane Database Syst Rev. 2022 May 4;5(5):CD007411. doi: 10.1002/14651858.CD007411.pub5.
10
Methods for blood loss estimation after vaginal birth.阴道分娩后失血估计方法。
Cochrane Database Syst Rev. 2018 Sep 13;9(9):CD010980. doi: 10.1002/14651858.CD010980.pub2.

引用本文的文献

1
Phentermine Use During First and Second Trimesters Associated with Fetal Stroke.妊娠前三个月和第二个三个月期间使用苯丁胺与胎儿中风有关。
Cureus. 2019 Nov 16;11(11):e6170. doi: 10.7759/cureus.6170.
2
Bariatric surgery and birth defects: A systematic literature review.减肥手术与出生缺陷:一项系统的文献综述。
Paediatr Perinat Epidemiol. 2018 Nov;32(6):533-544. doi: 10.1111/ppe.12517. Epub 2018 Oct 11.

本文引用的文献

1
Practice Bulletin No. 156: Obesity in Pregnancy: Correction.第156号实践公告:妊娠期肥胖:勘误。
Obstet Gynecol. 2016 Dec;128(6):1450. doi: 10.1097/AOG.0000000000001807.
2
New Dietary Supplements for Obesity: What We Currently Know.肥胖症的新膳食补充剂:目前我们所了解的情况。
Curr Obes Rep. 2016 Jun;5(2):262-70. doi: 10.1007/s13679-016-0214-y.
3
Weight management in obesity - past and present.肥胖症的体重管理——过去与现在
Int J Clin Pract. 2016 Mar;70(3):206-17. doi: 10.1111/ijcp.12771. Epub 2016 Jan 26.
4
Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011.美国 1995-2011 年因强制叶酸强化而预防神经管缺陷的最新估计。
MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):1-5.
5
Antiobesity drugs in early pregnancy and congenital malformations in the offspring.孕早期使用抗肥胖药物与子代先天性畸形
Obes Res Clin Pract. 2014 Nov-Dec;8(6):e571-6. doi: 10.1016/j.orcp.2013.11.008. Epub 2013 Dec 17.
6
Meta- and cost-effectiveness analysis of commercial weight loss strategies.商业减肥策略的荟萃分析和成本效益分析。
Obesity (Silver Spring). 2014 Sep;22(9):1942-51. doi: 10.1002/oby.20824. Epub 2014 Jun 24.
7
Long-term drug treatment for obesity: a systematic and clinical review.长期药物治疗肥胖:系统评价和临床综述。
JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361.
8
Appetite suppressants in pregnancy.孕期食欲抑制剂
Neuro Endocrinol Lett. 2012;33 Suppl 3:179-82.
9
Attempts at weight loss in U.S. women with and without a history of gestational diabetes mellitus.美国有和无妊娠糖尿病史的女性减肥尝试。
Womens Health Issues. 2012 Sep;22(5):e447-53. doi: 10.1016/j.whi.2012.07.004.
10
Can benfluorex induce congenital malformations?苯氟雷司会导致先天性畸形吗?
Diabetes Metab. 2012 Oct;38(4):373-4. doi: 10.1016/j.diabet.2012.02.013. Epub 2012 May 3.

母亲使用减肥产品与子女神经管缺陷风险:系统文献回顾。

Maternal Use of Weight Loss Products and the Risk of Neural Tube Defects in Offspring: A Systematic Literature Review.

机构信息

UTHealth School of Public Health, Department of Epidemiology, Human Genetics, and Environmental Sciences, Houston, Texas.

出版信息

Birth Defects Res. 2018 Jan 15;110(1):48-55. doi: 10.1002/bdr2.1116. Epub 2017 Oct 12.

DOI:10.1002/bdr2.1116
PMID:29024488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8919237/
Abstract

BACKGROUND

Several studies have assessed potential associations between use of weight loss products in the periconceptional period and neural tube defects (NTDs). However, the individual studies are inconclusive and there has not been a systematic review of this literature.

METHODS

We conducted a systematic search, using Ovid MEDLINE and PubMed, to identify studies that evaluated the association between products used for weight loss and the risk of NTDs. Because many studies of birth defects only evaluate a composite birth defect outcome, we evaluated studies that defined the outcome as "any major birth defect" or as NTDs. We abstracted data on study design, exposure definition, outcome definition, covariates and effect size estimates from each article that met our inclusion criteria. For studies that evaluated a composite birth defect outcome, we also abstracted the number of NTD cases included in the composite outcome. We used a modified version of the Newcastle-Ottawa Scale to assess the quality of each article.

RESULTS

We screened 865 citations and identified nine articles that met our inclusion criteria. The majority of studies reported positive associations between maternal use of weight loss products and birth defects (overall and NTDs). However, there were few significant associations and there was considerable heterogeneity in the specific exposures assessed across the nine studies.

CONCLUSION

Our systematic review of weight loss products and NTDs indicates that the literature on this topic is sparse. Because several studies reported modest, positive associations between risk and use of weight loss products, additional studies are warranted. Birth Defects Research 110:48-55, 2018. © 2017 Wiley Periodicals, Inc.

摘要

背景

有几项研究评估了在围孕期使用减肥产品与神经管缺陷(NTD)之间的潜在关联。然而,个别研究的结论并不一致,也没有对这方面的文献进行系统评价。

方法

我们使用 Ovid MEDLINE 和 PubMed 进行了系统搜索,以确定评估用于减肥的产品与 NTD 风险之间关联的研究。由于许多出生缺陷的研究仅评估了复合出生缺陷的结果,因此我们评估了将结果定义为“任何重大出生缺陷”或 NTD 的研究。我们从符合纳入标准的每篇文章中提取了研究设计、暴露定义、结果定义、协变量和效应量估计的数据。对于评估复合出生缺陷结果的研究,我们还从复合结果中提取了 NTD 病例的数量。我们使用了纽卡斯尔-渥太华量表的修改版来评估每篇文章的质量。

结果

我们筛选了 865 条引文,确定了 9 篇符合纳入标准的文章。大多数研究报告了母亲使用减肥产品与出生缺陷(整体和 NTD)之间存在正相关。然而,仅有少数显著关联,而且在这 9 项研究中评估的具体暴露存在很大的异质性。

结论

我们对减肥产品与 NTD 进行的系统评价表明,关于这个主题的文献很少。由于几项研究报告了风险与使用减肥产品之间存在适度的正相关,因此需要进一步的研究。出生缺陷研究 110:48-55, 2018. © 2017 Wiley Periodicals, Inc.